<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02799979</url>
  </required_header>
  <id_info>
    <org_study_id>14-AOI-08</org_study_id>
    <nct_id>NCT02799979</nct_id>
  </id_info>
  <brief_title>3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension</brief_title>
  <acronym>HTP3S</acronym>
  <official_title>3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary hypertension is a rare and severe disease, affecting a young population. Survival
      is very poor and has been closely related to right ventricular dysfunction. Current
      prognostic equations rely mostly on right heart catheterization data. The identification of
      simple echocardiographic prognostic factor is urgently needed. It could help identifying with
      a non invasive method, high risk patients who could benefit from an intensive specific
      therapy. 3D right ventricular imaging is a new echocardiographic tool which provides RV
      volumic analysis, RV ejection fraction, overcoming the classical limits of 2D ultrasound.

      The aim of this study is to validate a new software for 3D analysis of the right ventricle
      and assess its prognostic role in pulmonary hypertension.

      To do so, the investigators will realize a prospective monocentric longitudinal cohort study,
      including 100 pulmonary hypertension patients. Echocardiographic data will be collected at
      baseline and after 6 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of death from any cause</measure>
    <time_frame>Baseline to 24 months</time_frame>
    <description>Description of the number of death during the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalisation</measure>
    <time_frame>Baseline to 24 months</time_frame>
    <description>Description of the number of hospitalisation for worsening of pulmonary arterial hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3D right ventricular imaging echocardiographic</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Analyse the data of 3D right ventricular (RV), ejection fraction, RV telediastolic and telesystolic volume, 3D RV area strain (%)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Echocardiographic data : 3D right ventricular imaging on 100 pulmonary hypertension patients at Baseline and after six months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Echocardiographic data : 3D right ventricular Imaging on 50 patients without pulmonary hypertension only at baseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D right ventricular imaging echocardiographic</intervention_name>
    <description>Echocardiographic data (3D right ventricular imaging echocardiographic) will be collected at baseline and after 6months.</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pulmonary hypertension diagnosed
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years old

          -  Pulmonary hypertension diagnosed by right heart catheterization

          -  Informed consent obtained

          -  Affiliation to the French national health insurance

        Exclusion Criteria:

          -  Associated significant left heart disease

          -  Sub-optimal acoustic windows

          -  Patient unable to attend follow-up visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PAMELA MOCERI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU NICE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PAMELA MOCERI, MD</last_name>
    <phone>4 92 03 77 34</phone>
    <phone_ext>+33</phone_ext>
    <email>moceri.p@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Pasteur - Chu Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PAMELA MOCERI, MD</last_name>
      <phone>4 92 03 77 34</phone>
      <phone_ext>+33</phone_ext>
      <email>moceri.p@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

